Investor Relations Corporate Profile Evolus is a medical aesthetics company focused on providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. FINANCIAL NEWS December 19, 2018 Evolus Added to NASDAQ Biotechnology Index November 26, 2018 Evolus to Participate in Global Mizuho Investor Conference November 19, 2018 Evolus Receives Conditional FDA Acceptance of Jeuveau™ Brand Name View all EVENTS Stifel 2018 Healthcare Conference Nov 13, 2018 at 8:00 AM EST Q3 2018 Evolus Earnings Conference Call Nov 5, 2018 at 4:30 PM EST Cantor Global Healthcare Conference Oct 1, 2018 at 8:55 AM EDT View all PRESENTATION January 2019 Investor Presentation Jan 04, 2019
